Are stem-cell therapies for parkinson’s disease ready for clinical trials?

Are stem-cell therapies for parkinson’s disease ready for clinical trials?

As stem cell-based therapies are moving rapidly towards clinical trials, treatments for Parkinson’s Disease (PD), an incurable condition, may be on the horizon. A recent announcement of a Phase I/IIa clinical trial involving transplantation of stem cells into the first human subjects has raised hope among patients and sparked discussions in the research community.

Written by 

June 2013 – Present: Program Manager, Memorial Sloan-Kettering Cancer Center July 2009 – June 2012: iPierian, Senior Scientist & Project Team Leader January 2007 – June 2009: Postdoctoral fellow, University Health Network October 2003 – December 2006: Postdoctoral fellow, Mount Sinai School of Medicine